Range
2.06 - 2.14
Vol / Avg.
1.8M/2.3M
Div / Yield
-
52 Wk
1.45 - 4.83
Mkt Cap
158.5M
Payout Ratio
-
Open
2.11
P/E
-
EPS
-0.15
Shares
76.2M
Outstanding
76.2M
Total Float
76.1M
load more
Sector: Health Care.Industry: Pharmaceuticals
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.120
REV0
Q4 2020Est.ActualSurprise
EPS-0.2000.010 0.2100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HEPAHepion Pharmaceuticals-1.42%158.5M

Hepion Pharmaceuticals Frequently Asked Questions

Q

How do I buy Hepion Pharmaceuticals (HEPA) stock?

A

You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hepion Pharmaceuticals's (HEPA) competitors?

Q

What is the target price for Hepion Pharmaceuticals (HEPA) stock?

A

The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Brookline Capital on November 22, 2019. The analyst firm set a price target for 12.00 expecting HEPA to rise to within 12 months (a possible 476.92% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Hepion Pharmaceuticals (HEPA)?

A

The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $2.08 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Hepion Pharmaceuticals (HEPA) pay a dividend?

A

There are no upcoming dividends for Hepion Pharmaceuticals.

Q

When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?

A
Hepion Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is Hepion Pharmaceuticals (HEPA) going to split?

A

There is no upcoming split for Hepion Pharmaceuticals.

Q

What sector and industry does Hepion Pharmaceuticals (HEPA) operate in?

A

Hepion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.